down arrow

Replimune Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76029N1063
  • NASDAQ: REPL
USD
12.96
-0.51 (-3.79%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryReplimune Group, Inc. VS Pharmaceuticals & Biotechnology
 
calendar-icon
calendar-icon
1D
-3.79%
-0.75%
1W
0%
2.04%
1M
-12.25%
0.41%
YTD
33.33%
12.57%
1Y
199.31%
15.76%
3Y
-22.77%
78.38%
5Y
-61.51%
73.21%
10Y
%
255.99%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.49%
0%
13.49%
6 Months
85.67%
0%
85.67%
1 Year
199.31%
0%
199.31%
2 Years
18.25%
0%
18.25%
3 Years
-22.77%
0%
-22.77%
4 Years
-18.39%
0%
-18.39%
5 Years
-61.51%
0%
-61.51%

Replimune Group, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading